当前位置: X-MOL 学术N. Engl. J. Med. › 论文详情
Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant
The New England Journal of Medicine ( IF 70.670 ) Pub Date : 2019-11-21 , DOI: 10.1056/nejmoa1910437
Zachariah DeFilipp; Patricia P. Bloom; Mariam Torres Soto; Michael K. Mansour; Mohamad R.A. Sater; Miriam H. Huntley; Sarah Turbett; Raymond T. Chung; Yi-Bin Chen; Elizabeth L. Hohmann

Fecal microbiota transplantation (FMT) is an emerging therapy for recurrent or refractory Clostridioides difficile infection and is being actively investigated for other conditions. We describe two patients in whom extended-spectrum beta-lactamase (ESBL)–producing Escherichia coli bacteremia occurred after they had undergone FMT in two independent clinical trials; both cases were linked to the same stool donor by means of genomic sequencing. One of the patients died. Enhanced donor screening to limit the transmission of microorganisms that could lead to adverse infectious events and continued vigilance to define the benefits and risks of FMT across different patient populations are warranted.
更新日期:2019-11-21

 

全部期刊列表>>
宅家赢大奖
向世界展示您的会议墙报和演示文稿
全球疫情及响应:BMC Medicine专题征稿
新版X-MOL期刊搜索和高级搜索功能介绍
化学材料学全球高引用
ACS材料视界
x-mol收录
自然科研论文编辑服务
南方科技大学
南方科技大学
西湖大学
中国科学院长春应化所于聪-4-8
复旦大学
课题组网站
X-MOL
深圳大学二维材料实验室张晗
中山大学化学工程与技术学院
试剂库存
天合科研
down
wechat
bug